ArticleCancer research communications2025

Efficacy of CBP/p300 Dual Inhibitors against Derepression of KREMEN2 in cBAF-Deficient Cancers.

Mariko Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.